OÜ Kantremaa Apteek
CopyRegistry data
Legal status
Company ID
12874796VAT code
EE101803892Registered
06/07/2015Share capital
2,500.00 €Activity
Retail sale of pharmaceutical products (47731 - EMTAK 2025)Contacts
Company registration address
Website
-
A
HighestReliability
A - Highest
+2 ** during past year
Number of employees
3Credit limit
30-50 k €Credit report
Company's financial performance and creditability assessment.+14.47 % ** during past year
Taxes
14.9KDebts
-+20.12 % ** during past year
Taxable turnover
249.4K
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Register and
explore Okredo data
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 786,000 |
| 393,000 |
| 74,702 |
| 67,242 |
| 33,621 |
| 0.32 |
| 0.31 |
| 24.18 |
| 190,049 |
| 24.14 |
| 189,712 |
| 17.81 |
| 8.55 |
| 251,290 |
| 77,771 |
| 182 |
| 328,879 |
| 2023 |
|---|
| 793,430 |
| 793,430 |
| 82,896 |
| 75,610 |
| 75,610 |
| 0.36 |
| 0.20 |
| 26.09 |
| 206,978 |
| 26.06 |
| 206,760 |
| 18.40 |
| 9.53 |
| 287,626 |
| 57,356 |
| 710 |
| 344,272 |
| 2024 |
|---|
| 917,990 |
| 458,995 |
| 108,515 |
| 90,699 |
| 45,350 |
| 0.32 |
| 0.25 |
| 26.38 |
| 242,171 |
| 26.36 |
| 241,997 |
| 17.32 |
| 9.88 |
| 294,631 |
| 74,288 |
| 536 |
| 368,383 |
| 2024 |
|---|
| 917,990 |
| 458,995 |
| 108,515 |
| 90,699 |
| 45,350 |
| 0.32 |
| 0.25 |
| 26.38 |
| 242,171 |
| 26.36 |
| 241,997 |
| 17.32 |
| 9.88 |
| 294,631 |
| 74,288 |
| 536 |
| 368,383 |
Register and
explore Okredo dataTurnover (€)
Register and
explore Okredo dataCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Retail sale of pharmaceutical productsComp. code:
16495021Reg. date:
06/05/2022Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
16086050Reg. date:
29/10/2020Turnover:
-No. of employees:
2Category:
Retail sale of pharmaceutical productsComp. code:
16007151Reg. date:
10/07/2020Turnover:
-No. of employees:
2Category:
Retail sale of pharmaceutical productsComp. code:
14853433Reg. date:
21/11/2019Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
14627458Reg. date:
17/12/2018Turnover:
-No. of employees:
2